Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Prothena Gross Profit 2011-2025 | PRTA

Prothena gross profit from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Prothena Annual Gross Profit
(Millions of US $)
2024 $135
2023 $91
2022 $54
2021 $201
2020 $1
2019 $1
2018 $1
2017 $28
2016 $1
2015 $2
2014 $51
2013 $1
2012 $3
2011 $1
2010 $1
Prothena Quarterly Gross Profit
(Millions of US $)
2025-03-31 $3
2024-12-31 $2
2024-09-30 $1
2024-06-30 $132
2024-03-31 $0
2023-12-31 $0
2023-09-30 $85
2023-06-30 $4
2023-03-31 $2
2022-12-31 $50
2022-09-30 $2
2022-06-30 $1
2022-03-31 $1
2021-12-31 $1
2021-09-30 $139
2021-06-30 $60
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $27
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $1
2014-12-31 $2
2014-09-30 $1
2014-06-30 $15
2014-03-31 $32
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $1
2012-09-30 $1
2012-06-30 $1
2012-03-31 $0
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.283B $0.135B
Prothena Corp. plc, being a clinical-stage neuroscience company, focused on the development of novel therapeutic therapies for life-threatening diseases. Its wholly owned programs include birtamimab for the potential treatment of AL amyloidosis, PRX004 for the potential treatment of ATTR amyloidosis and a portfolio of programs for the potential treatment of Alzheimer's disease including PRX012 that targets A?.?Prothena is also developing candidates in collaboration with bigwigs like Roche and Bristol-Myers Squibb. These programs include prasinezumab, in collaboration with Roche for the potential treatment of Parkinson's disease and other related synucleinopathies, and programs that target tau, TDP-43 and an undisclosed target in collaboration with Bristol-Myers Squibb for the potential treatment of Alzheimer's disease, amyotrophic lateralsclerosis, etc. It sold PRX004 and the broader ATTR amyloidosis program to Novo Nordisk. It derives revenues from license, development & commercialization agreements.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $228.967B 17.09
Amgen (AMGN) United States $157.779B 14.13
Gilead Sciences (GILD) United States $136.944B 14.22
Vertex Pharmaceuticals (VRTX) United States $115.949B 0.00
Bristol Myers Squibb (BMY) United States $101.693B 6.81
GSK (GSK) United Kingdom $84.648B 10.12
CSL (CSLLY) Australia $77.172B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.523B 13.72
Alnylam Pharmaceuticals (ALNY) United States $39.437B 0.00
Argenex SE (ARGX) Netherlands $35.137B 95.91
BioNTech SE (BNTX) Germany $25.696B 0.00
Biogen (BIIB) United States $19.853B 8.56
Royalty Pharma (RPRX) United States $18.880B 7.98
Insmed (INSM) United States $16.562B 0.00
Genmab (GMAB) Denmark $14.646B 16.43
Genmab (GNMSF) Denmark $14.413B 14.74
Illumina (ILMN) United States $13.927B 26.42
Incyte (INCY) United States $13.563B 103.04
Exelixis (EXEL) United States $11.596B 19.68
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
BioMarin Pharmaceutical (BMRN) United States $11.023B 17.91
Moderna (MRNA) United States $10.705B 0.00
Exact Sciences (EXAS) United States $10.598B 0.00
Ascendis Pharma (ASND) Denmark $10.529B 0.00
QIAGEN (QGEN) Netherlands $10.274B 19.99
Blueprint Medicines (BPMC) United States $8.265B 0.00
Bio-Techne Corp (TECH) United States $8.058B 30.06
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.999B 0.00
Revolution Medicines (RVMD) United States $7.820B 0.00
Roivant Sciences (ROIV) United Kingdom $7.729B 0.00
Repligen (RGEN) United States $7.465B 83.57
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.388B 0.00
Legend Biotech (LEGN) United States $6.917B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.838B 6.71
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.626B 12.68
TG Therapeutics (TGTX) United States $6.260B 164.29
Guardant Health (GH) United States $6.206B 0.00
Telix Pharmaceuticals (TLX) Australia $5.839B 0.00
Nuvalent (NUVL) United States $5.706B 0.00
Axsome Therapeutics (AXSM) United States $5.412B 0.00
Zealand Pharma (ZLDPF) Denmark $5.382B 0.00
Alkermes (ALKS) Ireland $5.122B 13.74
ADMA Biologics Inc (ADMA) United States $4.980B 37.25
Vaxcyte (PCVX) United States $4.799B 0.00
Zai Lab (ZLAB) China $4.413B 0.00
Akero Therapeutics (AKRO) United States $4.346B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.286B 0.00
Cytokinetics (CYTK) United States $4.125B 0.00
PTC Therapeutics (PTCT) United States $4.101B 7.14
Avidity Biosciences (RNA) United States $4.052B 0.00
Krystal Biotech (KRYS) United States $3.994B 30.78
Merus (MRUS) Netherlands $3.907B 0.00
Sarepta Therapeutics (SRPT) United States $3.840B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.715B 32.65
CRISPR Therapeutics AG (CRSP) Switzerland $3.708B 0.00
Metsera (MTSR) United States $3.687B 0.00
Arcellx (ACLX) United States $3.671B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.546B 0.00
SpringWorks Therapeutics (SWTX) United States $3.522B 0.00
Protagonist Therapeutics (PTGX) United States $3.494B 75.16
Viking Therapeutics (VKTX) United States $3.273B 0.00
Scholar Rock Holding (SRRK) United States $3.268B 0.00
Kymera Therapeutics (KYMR) United States $3.165B 0.00
Alvotech (ALVO) Luxembourg $3.126B 17.88
MoonLake Immunotherapeutics (MLTX) Switzerland $2.949B 0.00
ImmunityBio (IBRX) United States $2.948B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.936B 0.00
Immunovant (IMVT) United States $2.861B 0.00
Ascentage Pharma Group - (AAPG) China $2.605B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.468B 0.00
Apellis Pharmaceuticals (APLS) United States $2.461B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.426B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.344B 0.00
Vericel (VCEL) United States $2.301B 1523.33
Bavarian Nordic (BVNRY) Denmark $2.254B 11.91
Denali Therapeutics (DNLI) United States $2.217B 0.00
Ligand Pharmaceuticals (LGND) United States $2.188B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.172B 0.00
CG Oncology (CGON) United States $2.095B 0.00
Twist Bioscience (TWST) United States $2.064B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.059B 13.68
NovoCure (NVCR) Jersey $2.049B 0.00
Agios Pharmaceuticals (AGIO) United States $1.999B 0.00
IDEAYA Biosciences (IDYA) United States $1.982B 0.00
Belite Bio (BLTE) United States $1.948B 0.00
Certara (CERT) United States $1.945B 36.33
Apogee Therapeutics (APGE) United States $1.935B 0.00
Amicus Therapeutics (FOLD) United States $1.881B 203.67
Disc Medicine (IRON) United States $1.838B 0.00
Beam Therapeutics (BEAM) United States $1.818B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.805B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.730B 0.00
Biohaven (BHVN) United States $1.714B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.656B 0.00
Edgewise Therapeutics (EWTX) United States $1.625B 0.00
Mesoblast (MESO) Australia $1.624B 0.00
BGM Group (BGM) China $1.591B 0.00
Adaptive Biotechnologies (ADPT) United States $1.589B 0.00
Janux Therapeutics (JANX) United States $1.553B 0.00
GRAIL (GRAL) United States $1.516B 0.00
89BIO (ETNB) United States $1.501B 0.00
Vera Therapeutics (VERA) United States $1.443B 0.00
Celldex Therapeutics (CLDX) United States $1.389B 0.00
ANI Pharmaceuticals (ANIP) United States $1.362B 14.03
Travere Therapeutics (TVTX) United States $1.344B 0.00
Liquidia Technologies (LQDA) United States $1.281B 0.00
Viridian Therapeutics (VRDN) United States $1.258B 0.00
Dynavax Technologies (DVAX) United States $1.252B 74.50
Structure Therapeutics (GPCR) United States $1.252B 0.00
Anbio Biotechnology (NNNN) Germany $1.246B 0.00
MannKind (MNKD) United States $1.191B 24.50
Novavax (NVAX) United States $1.166B 2.72
Pacira BioSciences (PCRX) United States $1.151B 10.96
Spyre Therapeutics (SYRE) United States $1.119B 0.00
WAVE Life Sciences (WVE) Singapore $1.114B 0.00
Niagen Bioscience (NAGE) United States $1.065B 150.22
Arcus Biosciences (RCUS) United States $1.061B 0.00
Mineralys Therapeutics (MLYS) United States $1.045B 0.00
Geron (GERN) United States $1.019B 0.00
CorMedix Inc (CRMD) United States $1.010B 67.68
NeoGenomics (NEO) United States $1.009B 0.00
Nurix Therapeutics (NRIX) United States $0.975B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.967B 0.00
MiMedx (MDXG) United States $0.964B 23.32
CureVac (CVAC) Germany $0.958B 4.64
Pharvaris (PHVS) Netherlands $0.948B 0.00
Praxis Precision Medicines (PRAX) United States $0.934B 0.00
Zymeworks (ZYME) United States $0.909B 0.00
AbCellera Biologics (ABCL) Canada $0.901B 0.00
UniQure (QURE) Netherlands $0.895B 0.00
Intellia Therapeutics (NTLA) United States $0.877B 0.00
Oculis Holding AG (OCS) Switzerland $0.864B 0.00
Nuvation Bio (NUVB) United States $0.861B 0.00
Cogent Biosciences (COGT) United States $0.845B 0.00
Gyre Therapeutics (GYRE) United States $0.844B 225.00
ArriVent BioPharma (AVBP) United States $0.838B 0.00
Immunome (IMNM) United States $0.833B 0.00
Sionna Therapeutics (SION) United States $0.806B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Iovance Biotherapeutics (IOVA) United States $0.795B 0.00
LENZ Therapeutics (LENZ) United States $0.790B 0.00
Pharming Group (PHAR) Netherlands $0.784B 0.00
Replimune (REPL) United States $0.781B 0.00
Trevi Therapeutics (TRVI) United States $0.764B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Vir Biotechnology (VIR) United States $0.749B 0.00
Immatics (IMTX) Germany $0.722B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.708B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
Anavex Life Sciences (AVXL) United States $0.693B 0.00
Oric Pharmaceuticals (ORIC) United States $0.693B 0.00
Bicara Therapeutics (BCAX) United States $0.686B 0.00
Arbutus Biopharma (ABUS) United States $0.680B 0.00
GH Research (GHRS) Ireland $0.668B 0.00
Sana Biotechnology (SANA) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.634B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.626B 0.00
Upstream Bio (UPB) United States $0.623B 0.00
Stoke Therapeutics (STOK) United States $0.620B 14.38
Autolus Therapeutics (AUTL) United Kingdom $0.620B 0.00
Dianthus Therapeutics (DNTH) United States $0.603B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.598B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.596B 0.00
Kura Oncology (KURA) United States $0.590B 0.00
Arvinas (ARVN) United States $0.571B 0.00
Tyra Biosciences (TYRA) United States $0.569B 0.00
Maze Therapeutics (MAZE) United States $0.564B 0.00
Keros Therapeutics (KROS) United States $0.558B 0.00
MeiraGTx Holdings (MGTX) United States $0.551B 0.00
Cullinan Therapeutics (CGEM) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Castle Biosciences (CSTL) United States $0.521B 35.37
Zenas BioPharma (ZBIO) United States $0.500B 0.00
Abivax SA (ABVX) France $0.499B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.498B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
REGENXBIO (RGNX) United States $0.492B 0.00
Fortrea Holdings (FTRE) United States $0.490B 13.52
ATyr Pharma (ATYR) United States $0.490B 0.00
Celcuity (CELC) United States $0.489B 0.00
Tango Therapeutics (TNGX) United States $0.485B 0.00
Myriad Genetics (MYGN) United States $0.482B 0.00
Rapport Therapeutics (RAPP) United States $0.480B 0.00
Tectonic Therapeutic (TECX) United States $0.470B 0.00
PureTech Health (PRTC) United States $0.459B 0.00
Septerna (SEPN) United States $0.458B 0.00
Erasca (ERAS) United States $0.456B 0.00
Precigen (PGEN) United States $0.455B 0.00
Cytek Biosciences (CTKB) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.438B 0.00
Benitec Biopharma (BNTC) United States $0.425B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.421B 0.00
Eton Pharmaceuticals (ETON) United States $0.421B 0.00
Humacyte (HUMA) United States $0.414B 0.00
Kamada (KMDA) Israel $0.402B 24.10
Northwest Biotherapeutics (NWBO) United States $0.395B 0.00
Absci (ABSI) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
MBX Biosciences (MBX) United States $0.383B 0.00
Rezolute (RZLT) United States $0.375B 0.00
Solid Biosciences (SLDB) United States $0.374B 0.00
Fulcrum Therapeutics (FULC) United States $0.372B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Emergent Biosolutions (EBS) United States $0.366B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.364B 0.00
Terns Pharmaceuticals (TERN) United States $0.355B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.350B 0.00
Inventiva S.A (IVA) France $0.349B 0.00
Compass Therapeutics (CMPX) United States $0.347B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.337B 0.00
Verastem (VSTM) United States $0.336B 0.00
Abeona Therapeutics (ABEO) United States $0.330B 0.00
Ocugen (OCGN) United States $0.330B 0.00
Cidara Therapeutics (CDTX) United States $0.328B 0.00
Urogen Pharma (URGN) United States $0.325B 0.00
Astria Therapeutics (ATXS) United States $0.322B 0.00
Allogene Therapeutics (ALLO) United States $0.319B 0.00
Alpha Teknova (TKNO) United States $0.316B 0.00
Entrada Therapeutics (TRDA) United States $0.313B 10.20
Monte Rosa Therapeutics (GLUE) United States $0.312B 63.50
Neurogene (NGNE) United States $0.308B 0.00
XOMA Royalty (XOMA) United States $0.299B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.295B 0.00
Candel Therapeutics (CADL) United States $0.293B 0.00
Palvella Therapeutics (PVLA) United States $0.290B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.290B 0.00
Annexon (ANNX) United States $0.290B 0.00
Olema Pharmaceuticals (OLMA) United States $0.288B 0.00
Cardiff Oncology (CRDF) United States $0.286B 0.00
Gossamer Bio (GOSS) United States $0.284B 0.00
Cartesian Therapeutics (RNAC) United States $0.280B 0.00
Atea Pharmaceuticals (AVIR) United States $0.276B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.275B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Amarin (AMRN) Ireland $0.265B 0.00
Foghorn Therapeutics (FHTX) United States $0.258B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Aardvark Therapeutics (AARD) United States $0.255B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.253B 0.00
DBV Technologies S.A (DBVT) France $0.247B 0.00
Instil Bio (TIL) United States $0.246B 0.00
MaxCyte (MXCT) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.244B 0.00
Third Harmonic Bio (THRD) United States $0.239B 0.00
BioStem Technologies (BSEM) $0.234B 9.54
Y-mAbs Therapeutics (YMAB) United States $0.231B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
ScPharmaceuticals (SCPH) United States $0.225B 0.00
Kodiak Sciences (KOD) United States $0.223B 0.00
Inhibrx Biosciences (INBX) United States $0.222B 0.13
AC Immune (ACIU) Switzerland $0.221B 0.00
CytomX Therapeutics (CTMX) United States $0.218B 5.62
I-Mab (IMAB) United States $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
GENFIT S.A (GNFT) France $0.212B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
Monopar Therapeutics (MNPR) United States $0.211B 0.00
Prime Medicine (PRME) United States $0.204B 0.00
Codexis (CDXS) United States $0.202B 0.00
Bright Minds Biosciences (DRUG) United States $0.199B 0.00
Voyager Therapeutics (VYGR) United States $0.191B 0.00
Fate Therapeutics (FATE) United States $0.191B 0.00
Ventyx Biosciences (VTYX) United States $0.189B 0.00
Nuvectis Pharma (NVCT) United States $0.188B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.186B 0.00
Innate Pharma S.A (IPHA) France $0.183B 0.00
Sagimet Biosciences (SGMT) United States $0.182B 0.00
INmune Bio (INMB) United States $0.181B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.179B 0.00
Puma Biotechnology (PBYI) United States $0.179B 4.68
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
Editas Medicine (EDIT) United States $0.176B 0.00
Actuate Therapeutics (ACTU) United States $0.169B 0.00
Anika Therapeutics (ANIK) United States $0.166B 0.00
Neumora Therapeutics (NMRA) United States $0.165B 0.00
EnGene Holdings (ENGN) Canada $0.164B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.160B 0.00
Compugen (CGEN) Israel $0.160B 0.00
Spero Therapeutics (SPRO) United States $0.159B 0.00
Alector (ALEC) United States $0.159B 0.00
Alumis (ALMS) United States $0.159B 0.00
Rapt Therapeutics (RAPT) United States $0.157B 0.00
BioAge Labs (BIOA) United States $0.157B 0.00
Kyverna Therapeutics (KYTX) United States $0.156B 0.00
Galena Biopharma (SLS) United States $0.154B 0.00
Molecular Partners AG (MOLN) Switzerland $0.149B 0.00
Agenus (AGEN) United States $0.147B 0.00
23andMe Holding (MEHCQ) United States $0.145B 0.00
Alpha Cognition (ACOG) Canada $0.145B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.143B 0.00
Nkarta (NKTX) United States $0.141B 0.00
Black Diamond Therapeutics (BDTX) United States $0.140B 41.00
Seer (SEER) United States $0.131B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.128B 0.00
Contineum Therapeutics (CTNM) United States $0.126B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.121B 0.00
Sangamo Therapeutics (SGMO) United States $0.120B 0.00
Cabaletta Bio (CABA) United States $0.119B 0.00
BioHarvest Sciences (BHST) Canada $0.119B 0.00
TuHURA Biosciences (HURA) United States $0.119B 0.00
Theratechnologies (THTX) Canada $0.119B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.117B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
Caribou Biosciences (CRBU) United States $0.113B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.112B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
C4 Therapeutics (CCCC) United States $0.111B 0.00
Invivyd (IVVD) United States $0.109B 0.00
BeyondSpring (BYSI) United States $0.101B 0.00
Genelux (GNLX) United States $0.101B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
Entera Bio (ENTX) Israel $0.097B 0.00
TScan Therapeutics (TCRX) United States $0.096B 0.00
Biomea Fusion (BMEA) United States $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.095B 0.00
Pliant Therapeutics (PLRX) United States $0.095B 0.00
Coya Therapeutics (COYA) United States $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.094B 0.00
Coherus BioSciences (CHRS) United States $0.093B 0.00
Climb Bio (CLYM) United States $0.093B 0.00
Adagene (ADAG) China $0.092B 0.00
Citius Oncology (CTOR) United States $0.092B 0.00
XBiotech (XBIT) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.088B 0.00
Jasper Therapeutics (JSPR) United States $0.087B 0.00
Immunic (IMUX) United States $0.085B 0.00
Inovio Pharmaceuticals (INO) United States $0.083B 0.00
Elutia (ELUT) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Forte Biosciences (FBRX) United States $0.081B 0.00
Senti Biosciences (SNTI) United States $0.079B 0.00
Cellectis S.A (CLLS) France $0.078B 0.00
Immuneering (IMRX) United States $0.078B 0.00
PDS Biotechnology (PDSB) United States $0.077B 0.00
TELA Bio (TELA) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Skye Bioscience (SKYE) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Seres Therapeutics (MCRB) United States $0.072B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.071B 0.00
OKYO Pharma (OKYO) $0.070B 0.00
Ikena Oncology (IKNA) United States $0.070B 0.00
MediciNova (MNOV) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Adicet Bio (ACET) United States $0.068B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.067B 0.00
Akoya Biosciences (AKYA) United States $0.066B 0.00
Renovaro (RENB) United States $0.065B 0.00
Repare Therapeutics (RPTX) Canada $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Opus Genetics (IRD) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Exicure (XCUR) United States $0.061B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Adverum Biotechnologies (ADVM) United States $0.058B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Precision BioSciences (DTIL) United States $0.058B 0.00
Kalaris Therapeutics (KLRS) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Annovis Bio (ANVS) United States $0.056B 0.00
Shattuck Labs (STTK) United States $0.056B 0.00
Applied Therapeutics (APLT) United States $0.055B 0.00
Quince Therapeutics (QNCX) United States $0.055B 0.00
Atara Biotherapeutics (ATRA) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Mersana Therapeutics (MRSN) United States $0.051B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
PepGen (PEPG) United States $0.049B 0.00
RenovoRx (RNXT) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.045B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
Connect Biopharma Holdings (CNTB) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.041B 0.00
OnKure Therapeutics (OKUR) United States $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
Quantum Biopharma (QNTM) Canada $0.039B 0.00
Clene (CLNN) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.037B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
FibroBiologics (FBLG) United States $0.036B 0.00
CAMP4 Therapeutics (CAMP) United States $0.035B 0.00
Kezar Life Sciences (KZR) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Passage Bio (PASG) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.029B 0.00
Vor Biopharma (VOR) $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
Generation Bio (GBIO) United States $0.029B 0.00
Imunon (IMNN) United States $0.028B 0.00
BioAtla (BCAB) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
Gelteq (GELS) Australia $0.028B 0.00
Curis (CRIS) United States $0.026B 0.00
CalciMedica (CALC) United States $0.026B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Cingulate (CING) United States $0.021B 0.00
X4 Pharmaceuticals (XFOR) United States $0.021B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Femasys (FEMY) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.020B 0.00
Advanced Biomed (ADVB) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Abpro Holdings (ABP) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Rallybio (RLYB) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
NextCure (NXTC) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Evogene (EVGN) Israel $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
IN8bio (INAB) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00